| dc.contributor.author |
de Silva, H.A. |
en_US |
| dc.contributor.author |
Gunatilake, S.B. |
en_US |
| dc.date.accessioned |
2014-10-29T09:19:28Z |
|
| dc.date.available |
2014-10-29T09:19:28Z |
|
| dc.date.issued |
2002 |
en_US |
| dc.identifier.citation |
The Sri Lanka Prescriber. 2002; 10(1/2): pp.5-6 |
en_US |
| dc.identifier.issn |
1391-0736(Print) |
en_US |
| dc.identifier.uri |
http://repository.kln.ac.lk/handle/123456789/1502 |
|
| dc.description.abstract |
No Abstract Available |
|
| dc.publisher |
State Pharmaceuticals Corporation |
en_US |
| dc.subject |
Alzheimer Disease |
en_US |
| dc.title |
Rivastigmine in the treatment of Alzheimer's disease |
en_US |
| dc.type |
Report |
en_US |
| dc.identifier.department |
Pharmacology |
en_US |
| dc.identifier.department |
Medicine |
en_US |
| dc.creator.corporateauthor |
Department of Pharmacology, University of Colombo |
en_US |
| dc.creator.corporateauthor |
State Pharmaceuticals Corporation |
en_US |